These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14113821)

  • 21. [ON HETEROLOGOUS ANTIBODY FORMATION AFTER ORAL POLIOMYELITIS VACCINATION].
    SCHMIDT J; NAUMANN G
    Z Immunitats Allergieforsch; 1964 Jul; 127():64-74. PubMed ID: 14259857
    [No Abstract]   [Full Text] [Related]  

  • 22. [ON THE PROBLEM OF DISEASES SIMULATING POLIOMYELITIS].
    TSUKER MB; VOROSHILOVA MK; LESHCHINSKAIA EV; BELIAEVA AP; ANDREEVA AS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1963; 63():1471-7. PubMed ID: 14183976
    [No Abstract]   [Full Text] [Related]  

  • 23. [SOME GENERALITIES ABOUT POLIOMYELITIS].
    OLAIZOLASARRIA B
    Acta Pediatr Esp; 1964 Feb; 22():59-64. PubMed ID: 14136260
    [No Abstract]   [Full Text] [Related]  

  • 24. A SERUM INHIBITOR IN ANIMAL AND HUMAN SERA OF BOVINE ENTEROVIRUSES. II. IN VIVO ACTIVITY AND ROLE IN "NATURAL" RESISTANCE TO INFECTION.
    KLEIN M; DEFOREST A
    J Immunol; 1964 May; 92():822-6. PubMed ID: 14170425
    [No Abstract]   [Full Text] [Related]  

  • 25. TRANSMISSION OF POLIO VIRUS VACCINE BY CONTAMINATED BARIUM ENEMA WITH RESULTANT ANTIBODY RISE.
    MEYERS PH; RICHARDS M
    Am J Roentgenol Radium Ther Nucl Med; 1964 Apr; 91():864-5. PubMed ID: 14139914
    [No Abstract]   [Full Text] [Related]  

  • 26. [VIROLOGICAL STUDIES ON 2 PATIENTS WITH PARESIS IN CHRONOLOGICAL RELATION TO VACCINATION WITH ORAL POLIOVACCINE IN APRIL-MAY 1963].
    HAHNEMANN F; SIBONI K; GODTFREDSEN A; VON MAGNUS
    Fra Sundhedsstyr; 1963 Oct; 125():72-3. PubMed ID: 14095905
    [No Abstract]   [Full Text] [Related]  

  • 27. [ON THE EFFECT OF DEXTRAN SULFATE ON SABIN ORAL POLIOMYELITIS VACCINAL STRAINS].
    VOSS H
    Z Naturforsch B; 1964 Mar; 19():226-9. PubMed ID: 14175997
    [No Abstract]   [Full Text] [Related]  

  • 28. [OBSERVATIONS ON THE CULTURE OF POLIOVIRUS STRAINS FROM THE BLOOD AFTER VACCINATION WITH SABIN VACCINE L SC 2 AB].
    GRUETZNER L
    Zentralbl Bakteriol Orig; 1963 Dec; 191():90-1. PubMed ID: 14119947
    [No Abstract]   [Full Text] [Related]  

  • 29. [WHAT DOES THE TESTING OF VIRAL VACCINES DO FOR THE HARMLESSNESS OF VACCINES IN THEIR PRACTICAL USE?].
    BONIN O; GUENTHER O
    Med Welt; 1964 Apr; 15():822-31. PubMed ID: 14194499
    [No Abstract]   [Full Text] [Related]  

  • 30. EPIDEMIOLOGICAL ASPECTS OF COXSACKIE AND ECHO VIRUS INFECTIONS IN TROPICAL AREAS.
    FOX JP
    Am J Public Health Nations Health; 1964 Jul; 54(7):1134-42. PubMed ID: 14157847
    [No Abstract]   [Full Text] [Related]  

  • 31. [THE VALUE OF GENETIC MARKERS OF THE POLIOVIRUS FOR THE EVALUATION OF SUPPOSED INCIDENTS FOLLOWING ORAL VACCINATION].
    POETSCH F
    Zentralbl Bakteriol Orig; 1963 Dec; 191():112-6. PubMed ID: 14119890
    [No Abstract]   [Full Text] [Related]  

  • 32. [STUDIES ON THE TOLERANCE AND EFFICACY OF LIVE POLIOMYELITIS VIRUS VACCINE TYPE I].
    HENNESSEN W; ALTEVOGT R; MAULER R; LANGE A; BOEHM R
    Dtsch Med Wochenschr; 1963 Dec; 88():2387-90. PubMed ID: 14163000
    [No Abstract]   [Full Text] [Related]  

  • 33. EXPERIENCE IN THE ADMINISTRATION OF LIVE ATTENUATED POLIOVIRUS VACCINE (SABIN) IN INFANTS, WITH REFERENCE TO THE RELATION BETWEEN POLIO AND NON-POLIO VIRUSES.
    KONISHI S; SASATANI M; HAYAKAWA Y; KUROSE T; ASHIHARA Y
    Shonika Kiyo; 1963; 9():283-96. PubMed ID: 14112921
    [No Abstract]   [Full Text] [Related]  

  • 34. POLIOVIRUS IN FEBRILE VACCINEES.
    KELLY S; FOX JP; SPIGLAND I
    Arch Environ Health; 1965 Jan; 10():16-20. PubMed ID: 14219480
    [No Abstract]   [Full Text] [Related]  

  • 35. RESULTS OF INVESTIGATION OF TYPE 1 VIRUSES ISOLATED FROM PARALYTIC PATIENTS IN THE PERIOD FOLLOWING MASS VACCINATION WITH SABIN'S VACCINE IN CZECHOSLOVAKIA IN 1960.
    VONKA V; JANDA Z; SIMON J; ADAM E; ZAVADOVA H
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():58-76. PubMed ID: 14128980
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anti-poliomyelitis vaccination with attenuated live virus].
    BONNET F; LAMBRECHTS A
    Rev Med Liege; 1963 Mar; 18():140-8. PubMed ID: 13968824
    [No Abstract]   [Full Text] [Related]  

  • 37. STRAIN SPECIFICITY OF TYPE 1 NEUTRALIZING ANTIBODIES DEVELOPING IN CHILDREN FED WITH TYPE 1 SABIN'S ATTENUATED VIRUS (LSC 2AB).
    VONKA V; TARABCAK M; JANDA Z
    Arch Gesamte Virusforsch; 1964; 14():169-76. PubMed ID: 14141577
    [No Abstract]   [Full Text] [Related]  

  • 38. THERMORESISTANCE TESTING FOR IDENTIFICATION OF LSC 2AB VIRUS PROGENY.
    JANDA Z; VONKA V
    Arch Gesamte Virusforsch; 1964; 14():227-37. PubMed ID: 14141582
    [No Abstract]   [Full Text] [Related]  

  • 39. [ON THE LOSS OF NEUTRALIZING PROPERTIES OF POLIOMYELITIS VIRUS IN THE COURSE OF ITS ADSORPTION IN EPITHELIAL KIDNEY CELLS OF M. RHESUS].
    LANGE A; ZUR HAUSEN
    Z Hyg Infektionskr; 1964 Dec; 150():179-84. PubMed ID: 14335617
    [No Abstract]   [Full Text] [Related]  

  • 40. Serological investigations on children vaccinated with inactivated or live modified virus antipolio vaccines.
    CAJAL N; IANCONESCU M; ADERCA I; GRUIA M; CEPLEANU M; DANIELESCU S; OPRESCU E; CIOBANESCU M
    Rev Sci Med; 1963; 8():11-3. PubMed ID: 14017770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.